Varaico: Literature-Extracted Genetic Variants

Gene:VHL
Variant:p.Y156C
Back to variants list

VHL

NM_000551.4:p.Y156C

Associated Papers

Genotype-phenotype correlation in Iranian retinal hemangioblastoma patients and genetic diagnosis algorithm for Von Hippel-Lindau disease.

Azimi F et al.

Ophthalmic Genetics, 2025

Genotype-specific neoplastic risk profiles in patients with VHL disease.

Ganner A et al.

Endocrine-related Cancer, 2025

40202835 (PubMed )
Supplement: supplementary_materials.pdf

Pheochromocytoma in von Hippel-Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma.

Li T et al.

Clinical Endocrinology, 2025

Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease.

Knoblauch AL et al.

Journal of Neuro-oncology, 2024

38647646 (PubMed )
Supplement: 11060_2024_4676_MOESM1_ESM.pdf

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles.

Buckley M et al.

Nature Genetics, 2024

38969834 (PubMed )
Supplement: 41588_2024_1800_MOESM4_ESM.xlsx › ST2

Surveillance in Children and Adolescents with von Hippel-Lindau (VHL)-Related Pheochromocytomas and Paragangliomas: A Survey of MET and Freiburg-VHL Registries in Germany.

Kotsis F et al.

Journal of Kidney Cancer and Vhl, 2024

Investigation of germline VHL variants in Iranian patients with retinal capillary hemangioblastoma and genotype-phenotype analysis.

Naseripour M et al.

Ophthalmic Genetics, 2023

Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience.

Lima JV et al.

Endocrine Oncology (bristol, England), 2023

Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.

Chiorean A et al.

Human Mutation, 2022

35475554 (PubMed )
Supplement: HUMU-43-1268-s002.xlsx › Data_1

Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.

Chen JL et al.

Annual Review of Genomics and Human Genetics, 2022

36044908 (PubMed )
Supplement: gg23-giannikou_suptable1.xlsx › VHL

Clinical, Biochemical, Tumoural and Mutation Profile of VHL- and MEN2A-Associated Pheochromocytoma: A Comparative Study.

Dhanda M et al.

World Journal of Surgery, 2022

Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.

Singh D et al.

Nuclear Medicine Communications, 2020

Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.

Neumann HPH et al.

Jama Network Open, 2019

31397861 (PubMed )
Supplement: jamanetwopen-2-e198898-s001.pdf

Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors.

Minervini G et al.

Plos Computational Biology, 2019

30943211 (PubMed )
Supplement: pcbi.1006478.s001.xlsx › AlignGVGD

Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.

Krauss T et al.

Endocrine-related Cancer, 2018

GESPA: classifying nsSNPs to predict disease association.

Khurana JK et al.

Bmc Bioinformatics, 2015

26206375 (PubMed )
Supplement: 12859_2015_673_MOESM2_ESM.xls › Sheet1

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.

Gossage L et al.

Human Molecular Genetics, 2014

24969085 (PubMed )
Supplement: supp_ddu321_ddu321supp_table.xlsx › Supplementary_Table_2A

Systematic comparison of sporadic and syndromic pancreatic islet cell tumors.

Erlic Z et al.

Endocrine-related Cancer, 2010

Genetic analysis of von Hippel-Lindau disease.

Nordstrom-O'Brien M et al.

Human Mutation, 2010

The Warburg effect is genetically determined in inherited pheochromocytomas.

Favier J et al.

Plos One, 2009

Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.

Gergics P et al.

European Journal of Endocrinology, 2009

Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.

Boedeker CC et al.

The Journal of Clinical Endocrinology and Metabolism, 2009

Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?

Pigny P et al.

European Journal of Endocrinology, 2009

Computational detection of deleterious SNPs and their effect on sequence and structural level of the VHL gene.

Rajasekaran R et al.

Mammalian Genome : Official Journal of the International Mammalian Genome Society, 2008

Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.

Amar L et al.

The Journal of Clinical Endocrinology and Metabolism, 2007

Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.

Gallou C et al.

Human Mutation, 2004

Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes.

Bauters C et al.

Journal of Medical Genetics, 2003

[Von Hippel-Lindau disease: a hereditary disease that impacts multiple tissues].

Richard S et al.

Presse Medicale (paris, France : 1983), 1998

Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.

Olschwang S et al.

Human Mutation, 1998

Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.

Prowse AH et al.

American Journal of Human Genetics, 1997

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."